Filing Details
- Accession Number:
- 0001179110-14-003128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-19 19:13:51
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-02-19
- Accepted Time:
- 2014-02-19 19:13:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Theravance Inc | THRX | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1421050 | Mathai Mammen | Theravance, Inc. 901 Gateway Blvd. South San Francisco CA 94080 | Svp, Research & Early Clin Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-14 | 30,400 | $39.26 | 191,223 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-14 | 4,600 | $40.04 | 186,623 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
- This transaction was executed in multiple trades at prices ranging from $38.78 to $39.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $39.80 to $40.38. The price reported above reflects the weighted average sale price.